buyout·deskPrivate equity, daily
Fri, Aug 28, 2026
Daily briefFriday, August 28, 2026
2 deals tracked · Updated 5:58 PM PDT·Full deal sheet
Secondary·Technology/Software·July 16, 2026

Verdane invests in Axoniq, Dawn Health, Frameo and XCI

The investor will support go-to-market, data, finance and talent initiatives across the European software portfolio.

Takeaways

  • Axoniq, Dawn Health, Frameo and XCI is a Portfolio of four European software, digital health and cybersecurity companies developed by Trifork Labs.
  • Verdane is investing in Axoniq, Dawn Health, Frameo and XCI.
  • The.
BuyerVerdane
TargetAxoniq, Dawn Health, Frameo and XCI
SellerTrifork Group
TypeSecondary
GeographyEurope
IndustryTechnology
Sub-sectorSoftware

Verdane acquired ownership stakes in four technology businesses from Trifork Labs, the venture-investment division of listed software company Trifork Group.

The portfolio includes event-sourcing software company Axoniq, digital health company Dawn Health, WiFi photo-frame software provider Frameo and communication-intelligence cybersecurity company XCI.

Verdane will own the businesses alongside Trifork Group and their management teams.

The investor said it will support go-to-market, data, finance and talent initiatives and may increase its stakes over time.

Financial terms were not disclosed.